166 related articles for article (PubMed ID: 31227821)
1. Public biotech 2018-the numbers.
Morrison C; Lähteenmäki R
Nat Biotechnol; 2019 Jul; 37(7):714-721. PubMed ID: 31227821
[No Abstract] [Full Text] [Related]
2. Public biotech 2009-the numbers.
Huggett B; Hodgson J; Lähteenmäki R
Nat Biotechnol; 2010 Aug; 28(8):793-9. PubMed ID: 20697401
[No Abstract] [Full Text] [Related]
3. Public biotech in 2015 - the numbers.
Morrison C; Lähteenmäki R
Nat Biotechnol; 2016 Jul; 34(7):709-15. PubMed ID: 27404879
[No Abstract] [Full Text] [Related]
4. Wrong numbers?
Nat Biotechnol; 2010 Aug; 28(8):761. PubMed ID: 20697382
[No Abstract] [Full Text] [Related]
5. Public biotech in 2014--the numbers.
Morrison C; Lähteenmäki R
Nat Biotechnol; 2015 Jul; 33(7):703-9. PubMed ID: 26154007
[No Abstract] [Full Text] [Related]
6. Public biotechnology 2005--the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
[TBL] [Abstract][Full Text] [Related]
7. Biotech R&D still reeling.
Lawrence S
Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
[No Abstract] [Full Text] [Related]
8. Public biotech 2012--the numbers.
Huggett B
Nat Biotechnol; 2013 Aug; 31(8):697-703. PubMed ID: 23929343
[No Abstract] [Full Text] [Related]
9. Public biotech 2006 - the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
[No Abstract] [Full Text] [Related]
10. Sunbaked biotechnology in Australia.
Littlejohn T
Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
[No Abstract] [Full Text] [Related]
11. The biotech drug market.
Lawrence S
Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
[No Abstract] [Full Text] [Related]
12. Biotech drug market steadily expands.
Lawrence S
Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
[No Abstract] [Full Text] [Related]
13. Public biotech 2008--the numbers.
Huggett B; Hodgson J; Lähteenmäki R
Nat Biotechnol; 2009 Aug; 27(8):710-21. PubMed ID: 19668175
[TBL] [Abstract][Full Text] [Related]
14. Biotech firms jump on SARS bandwagon.
Basu P
Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
[No Abstract] [Full Text] [Related]
15. Biotechnology in Ireland: hard work, money and the brain gain.
O'Neill MF
Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
[No Abstract] [Full Text] [Related]
16. A lifeline for the biotech sector.
Kessel M
Nat Biotechnol; 2009 Feb; 27(2):123-4. PubMed ID: 19204686
[No Abstract] [Full Text] [Related]
17. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
18. Bid to limit prices on drugs using 'public' discoveries.
Wadman M
Nature; 1998 May; 393(6683):297. PubMed ID: 9620788
[No Abstract] [Full Text] [Related]
19. The responsibilities of growing up.
Nat Biotechnol; 2006 Mar; 24(3):225. PubMed ID: 16525362
[No Abstract] [Full Text] [Related]
20. Public companies get creative in raising finance.
Hodgson J
Nat Biotechnol; 2010 Apr; 28(4):301-2. PubMed ID: 20379161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
